热门资讯> 正文
Predictive Oncology宣布1比15反向股票拆分
2025-09-25 20:17
- Predictive Oncology (NASDAQ:POAI) on Thursday said it will effect a 1-for-15 reverse stock split of its issued and outstanding shares of common stock.
- Predictive Oncology’s common stock will continue to be traded on Nasdaq under the symbol POAI and will begin trading on a reverse split-adjusted basis when the market opens on September 30, 2025.
- The reverse stock split is primarily intended to bring the company into compliance with the minimum bid price requirement to maintain the listing of the company’s common stock on Nasdaq.
- Prior to the reverse stock split, the company had 11.43M shares of its common stock outstanding and immediately following the reverse stock split, there will be 762,414 shares of its common stock outstanding.
- POAI +0.84% premarket to $1.19.
- Source: Press Release
More on Predictive Oncology
- Financial information for Predictive Oncology
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
